Approvals/TGA/ROSALEE 3 mg/30 micrograms drospirenone/ethinylestradiol 3 mg/30 micrograms tablet blister pack

Approved

STANDARD

ROSALEE 3 mg/30 micrograms drospirenone/ethinylestradiol 3 mg/30 micrograms tablet blister pack

Lupin Australia Pty Limited🇦🇺 Therapeutic Goods Administration

Approval Id: 31b77f9b4be4b445
Product Name: ROSALEE 3 mg/30 micrograms drospirenone/ethinylestradiol 3 mg/30 micrograms tablet blister pack
Artg Id: 407772
Artg Name: ROSALEE 3 mg/30 micrograms drospirenone/ethinylestradiol 3 mg/30 micrograms tablet blister pack
Sponsor: Lupin Australia Pty Limited
Company Detail Path: /organization/lupin-australia-pty-limited
Artg Date: 2023-09-14
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/65fb320059faac1ccf717d8b8954f88f.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/0dfd989d81305e0beb6a01c5add547db.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

31b77f9b4be4b445

Type

Standard